RQM+
Private Company
Funding information not available
Overview
RQM+ positions itself as 'The MedTech CRO,' a specialized service provider supporting the entire product lifecycle for medical technology companies. Founded in 2018 and headquartered in San Diego, the company leverages deep regulatory expertise and proprietary technology platforms to accelerate time-to-market and reduce risk for its clients, which include 19 of the top 20 medical device manufacturers. Its business model is built on flexible service offerings including consulting, outsourcing, and staff augmentation, supported by an FDA-recognized laboratory via its Jordi Labs division. RQM+ is a private, revenue-generating services company focused on enabling MedTech innovation rather than developing its own therapeutic or diagnostic products.
Technology Platform
Proprietary technology platforms for workflow and project management, claimed to deliver 50% efficiency gains. Integrated with FDA-recognized laboratory and material science services via Jordi Labs.
Opportunities
Risk Factors
Competitive Landscape
RQM+ competes in the specialized MedTech CRO space against other niche consultancies and the MedTech service divisions of larger, diversified CROs (e.g., IQVIA, Medpace, PPD). Its key differentiators are its exclusive MedTech focus, integrated service model (including its own lab), proprietary technology platforms, and claimed efficiency gains. Competition is based on expertise, reputation, global reach, and the ability to deliver predictable, accelerated outcomes.